NCT03876327

Brief Summary

this pilot study aims to further explore the potential usage of Fecal microbiota transplantation in treating constipation and possibly also motor symptoms in Parkinson's disease (PD) patients, and to increase understanding of the potential relationship between the identities of intestinal microbial communities and PD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_2 parkinson-disease

Timeline
Completed

Started Aug 2015

Longer than P75 for phase_2 parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 19, 2015

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

February 20, 2019

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 15, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

August 5, 2020

Status Verified

August 1, 2020

Enrollment Period

4.4 years

First QC Date

February 20, 2019

Last Update Submit

August 2, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • motor parkinsonian symptoms

    motor symptoms assessed by UPDRS III questionaire

    Change from baseline motor difficulties at 6 months

  • constipation level

    constipation will be assessed by a scoring system questionaire. 6 parameters are reviewed as scored fro 0 (mild symptom) to 4 (srvere symptom).

    Change from baseline constipation level at 6 months

Study Arms (3)

PD patients that will receive FMT

EXPERIMENTAL

fecal microbial transplantation once at the beginning of the study-15 patients.

Procedure: fecal microbial transplantation

PD patients that will not receive FMT

NO INTERVENTION

do not receive treatment-35 patients.

healthy people live with PD patients

NO INTERVENTION

do not receive treatment-50 participants.

Interventions

Fecal microbiota transplantation (FMT) is a technique in which intestinal microbiota are transferred from a healthy donor to the patient, with as primary goal to introduce - or restore - a stable and 'healthy' microbial community in the gut.

PD patients that will receive FMT

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects aged \> 50 years, diagnosed as suffering from PD and under follow up of the Movement Disorders Clinic in Soroka University Medical Center.
  • Subjects complaining of constipation .
  • Subjects who did not perform a screening colonoscopy for colon cancer.
  • Subjects who are clinically undertreated according to last Movement Disorders specialist's impression at the clinic visit.

You may not qualify if:

  • Subjects who do not complain of constipation or seem clinically stable properly treated pharmacologically.
  • Subjects who already underwent a screening colonoscopy for colon cancer.
  • Subjects who suffer from a cognitive decline and could not give their consent, or patients who refuse to undergo a colonoscopy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Soroka Medical Center

Beersheba, 151, Israel

Location

Related Publications (1)

  • Segal A, Zlotnik Y, Moyal-Atias K, Abuhasira R, Ifergane G. Fecal microbiota transplant as a potential treatment for Parkinson's disease - A case series. Clin Neurol Neurosurg. 2021 Aug;207:106791. doi: 10.1016/j.clineuro.2021.106791. Epub 2021 Jun 30.

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • arik segal, MD

    SOROKA MC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 3 groups were included in the study: 1. PD patients that will undergo FMT tretment and a half of year follow-up-15 patients. 2. PD patients that will not undergo FMT procedure and will donate stool sample only once-35 patients. 3. healthy PD relatives, that live with them and have similiar life styling and which will donate stool sample only once-50 participants.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 20, 2019

First Posted

March 15, 2019

Study Start

August 19, 2015

Primary Completion

December 30, 2019

Study Completion

June 30, 2020

Last Updated

August 5, 2020

Record last verified: 2020-08

Locations